Arkolith/Insider Trading/AVTE/Form 4

Gillies Hunter

CHIEF MEDICAL OFFICERAerovate Therapeutics, Inc. (AVTE) · full profile →Form 4 · filed May 17, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$84K
Net Open-Market Flow
-$84K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 17, 2024Sell(S)86$21.86$2K6K
May 17, 2024Sell(S)4K$21.07$82K6K
May 17, 2024Option exercise(M)4K$2.14$9K10K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 17, 2024Option exercise(M)4K—$011K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-013630) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML